Coronary heart disease in the first 30 years of the 21st century: Challenges and opportunities: The 33rd annual James B. Herrick lecture of the council on clinical cardiology of the American heart association

Circulation

Volumn 103, Issue 20, 2001, Pages 2428-2435

  Beller, George A ^a  

^a UNIVERSITY OF VIRGINIA HEALTH SYSTEM   (United States)

Author keywords

Coronary disease; Diabetes mellitus; Myocardial infarction; Obesity

Indexed keywords

ABCIXIMAB; ACETYLSALICYLIC ACID; ADENOSINE; BETA ADRENERGIC RECEPTOR BLOCKING AGENT; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR; FIBRINOGEN RECEPTOR ANTAGONIST; FIBRINOLYTIC AGENT; GLUCOSE; GLYCOSYLATED HEMOGLOBIN; HIGH DENSITY LIPOPROTEIN CHOLESTEROL; HYDROXYMETHYLGLUTARYL COENZYME A REDUCTASE INHIBITOR; LOW DENSITY LIPOPROTEIN CHOLESTEROL; RAMIPRIL; STREPTOKINASE; TISSUE PLASMINOGEN ACTIVATOR; TRIACYLGLYCEROL; VERY LOW DENSITY LIPOPROTEIN;

ACUTE HEART INFARCTION; ARTICLE; ATHEROSCLEROSIS; CLINICAL TRIAL; CORONARY ARTERY DILATATION; CORONARY STENT; DIET; EPIDEMIC; EXERCISE; HEALTH CARE COST; HEART FAILURE; HUMAN; INSULIN RESISTANCE; ISCHEMIC HEART DISEASE; LIFESTYLE; MORTALITY; NON INSULIN DEPENDENT DIABETES MELLITUS; OBESITY; PATHOPHYSIOLOGY; PREVALENCE; PRIORITY JOURNAL; PROGNOSIS; SURVIVAL;

EID: 0035933066     PISSN: 00097322     EISSN: None     Source Type: Journal    
DOI: 10.1161/01.CIR.103.20.2428     Document Type: Article

References (65)

1. The ACC at 50: A giant grew in Bethesda: The impact of the ACC on cardiovascular medicine
2. The recent decline in mortality from coronary heart disease, 1980-1990: The effect of secular trends in risk factors and treatment
3. Death rates from coronary disease: Progress and a puzzling paradox
4. Clinical features of sudden obstruction of coronary arteries
5. COHORT registry: Swedish national register of cardiac intensive care with 18,461 patients reporting on the influence of statin therapy at discharge and performance of early revascularisation procedures on one-year mortality
6. Early statin treatment following acute myocardial infarction and 1-year survival: The Swedish register of cardiac intensive care (RIKS-HIA)
7. ECC guidelines. Part 7, the era of reperfusion: Section 1, acute coronary syndromes (acute myocardial infarction)
8. Marrow stromal cells for cellular cardiomyoplasty: The importance of microenvironment for milieu dependent differentiation
9. Sudden death from cardiac arrest: Improving the odds
10. Mortality within 24 hours of thrombolysis for myocardial infarction: The importance of early reperfusion: The GUSTO investigators (Global Utilization of Streptokinase and Tissue Plasminogen Activator for Occluded Coronary Arteries)
11. Angiographic no-reflow phenomenon as a predictor of adverse long-term outcome in patients treated with percutaneous transluminal coronary angioplasty for first acute myocardial infarction
12. Coronary stenting plus platelet glycoprotein IIb/IIIa blockade compared with tissue plasminogen activator in acute myocardial infarction: Stent versus thrombolysis for occluded coronary arteries in patients with acute myocardial infarction study investigators
13. Adenosine as an adjunct to thrombolytic therapy for acute myocardial infarction: Results of a multicenter, randomized, placebo-controlled trial: The Acute Myocardial Infarction Study of Adenosine (AMISTAD) trial
14. Twenty year trends (1975-1995) in the incidence, in-hospital and long-term death rates associated with heart failure complicating acute myocardial infarction: A community-wide perspective
15. Survival outcomes 1 year after reperfusion therapy with either alteplase or reteplase for acute myocardial infarction: Results from the Global Utilization of Streptokinase and t-PA for Occluded Coronary Arteries (GUSTO) III trial
16. Primary coronary angioplasty vs thrombolysis for the management of acute myocardial infarction in elderly patients
17. Heart failure treatment with angiotensin-converting enzyme inhibitors in hospitalized medicare patients in 10 large states
18. Demographics and cardiology, 1950-2050
19. Incidence, clinical and etiologic features, and outcomes of advanced chronic heart failure: The EPICAL study (Epidémiologie de l'insuffisance cardiaque avancée en lorraine)
20. Evidence of improving prognosis in heart failure: Trends in case fatality in 66 547 patients hospitalized between 1986 and 1995
21. Progress in heart failure management? Lessons from the real world
22. New issues in the treatment of isolated systolic hypertension
23. The diabetes explosion
24. Global burden of diabetes, 1995-2025
25. The silent killer
26. Tests urged to fight diabetes' surge in obese kids
27. Mortality from coronary heart disease in subjects with type 2 diabetes and in nondiabetic subjects with and without prior myocardial infarction
28. Diabetes, other risk factors, and 12-yr cardiovascular mortality for men screened in the multiple risk factor intervention trial
29. Lipids, diabetes, and coronary heart disease: Insights from the Framingham study
30. Emerging concepts in the management of acute myocardial infarction in patients with diabetes mellitus
31. Impact of diabetes on long-term prognosis in patients with unstable angina and non-Q-wave myocardial infarction: Results of the OASIS (Organization to Assess Strategies for Ischemic Syndromes) registry
32. Short- and long-term mortality for patients undergoing primary angioplasty for acute myocardial infarction
33. Coronary revascularization in diabetic patients: A comparison of the randomized and observational components of the Bypass Angioplasty Revascularization Investigation (BARI)
34. Management of coronary artery disease: Therapeutic options in patients with diabetes
35. Effects of ramipril on cardiovascular and microvascular outcomes in people with diabetes mellitus: Results of the HOPE study and MICRO-HOPE substudy
36. Randomized trial of cholesterol lowering in 4444 patients with coronary heart disease: The Scandinavian Simvistatin survival study
37. Insulin resistance a multifaceted syndrome responsible for NIDDM, obesity, hypertension, dyslipidemia and atherosclerotic cardiovascular disease
38. Series introduction: The molecular and physiological basis of insulin resistance: Emerging implications for metabolic and cardiovascular diseases
39. Genetic variation in the gene encoding calpain-10 is associated with type 2 diabetes mellitus
40. Relation of glycohemoglobin and adiposity to atherosclerosis in youth: Pathobiological Determinants of Atherosclerosis in Youth (PDAY) research group
41. Increasing prevalence of overweight among US adults: The national health and nutrition examination surveys, 1960 to 1991
42. Annual deaths attributable to obesity in the United States
43. Caloric imbalance and public health policy
44. Overweight and obesity in the United States: Prevalence and trends, 1960-1994
45. The spread of the obesity epidemic in the United States 1991-1998
46. Americans need better diet, new health study reports
47. While children grow fatter, experts search for solutions
48. The relation of overweight to cardiovascular disease risk factors among children and adolescents: The Bogalusa heart study
49. Relationship between low cardiorespiratory fitness and mortality in normal weight, overweight, and obese men
50. Diabetes and diabetes risk factors in second- and third-generation Japanese Americans in Seattle, Washington
51. Type 2 diabetes and the metabolic syndrome in Japanese Americans
52. Changes in physical fitness and all-cause mortality: A prospective study of healthy and unhealthy men
53. Exercise as cardiovascular therapy
54. Physician counseling about exercise
55. Effects of lifestyle activity vs structured aerobic exercise in obese women: A randomized trial
56. Fitness gap is America's recipe for fat youth
57. Relationship of physical activity and television watching with body weight and level of fatness among children: Results from the third national health and nutrition examination survey
58. Primary care: Guidelines for healthy weight
59. The future of cardiology: Utilization and costs of care
60. Conquering cardiovascular disease: Progress and promise